gastroenterology Archives - PharmaDeviceNews

AbbVie’s AFFIRM trial: what clinicians should watch next for risankizumab in Crohn’s disease

By Pallavi Madhiraju on March 8, 2026 Pharma & Biotech

AbbVie reports positive Phase 3 AFFIRM trial results for risankizumab subcutaneous induction in Crohn’s disease. Discover what the findings mean for treatment.

Biomerica’s responder data raises new questions about diet-driven IBS management

By Soujanya Ravi on February 26, 2026 Medical Devices & Diagnostics

Biomerica reports real-world IBS responder data and Medicare coverage. Explore what this means for adoption, reimbursement, and competition.

RED-C setback for Bausch Health: What this failed Phase 3 trial reveals about cirrhosis care gaps

By Pallavi Madhiraju on January 24, 2026 Pharma & Biotech

Bausch’s RED-C trial failed to meet endpoints in hepatic encephalopathy prevention. Find out what this means for rifaximin SSD’s future and the field.